Your session is about to expire
← Back to Search
Metallic Copper
Copper Linen Exposure for Critical Illness in Critically Ill Patients (IMPACT Trial)
N/A
Waitlist Available
Led By Ebbing Lautenbach, MD,MPH,MSCE
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of icu (must be >48 hours) stay plus 2 additional hospital days
Awards & highlights
IMPACT Trial Summary
This trial will study whether using copper-based linens in hospitals can help reduce the spread of infection and drug-resistant bacteria.
Eligible Conditions
- Critically Ill Patients
IMPACT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of icu (must be >48 hours) stay plus 2 additional hospital days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of icu (must be >48 hours) stay plus 2 additional hospital days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of intensive care -related hospital-acquired infections or multi-drug resistant organisms
Side effects data
From 2020 Phase 4 trial • 711 Patients • NCT021750305%
Adverse events experienced related to IUD at 1-Month
100%
80%
60%
40%
20%
0%
Study treatment Arm
Copper T380 IUD
LNG20 IUD
IMPACT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Copper linen exposureExperimental Treatment1 Intervention
Subjects will use copper linens during their hospital stay, consisting of copper hospital gowns, copper bed sheets (top and bottom sheets), and copper pillow covers.
A subset of 50 subjects from this arm will be recruited to provide three types of swabs to calculate the microbial burden on copper linens. Linen swabs, anatomical swabs and environmental swabs will be collected from subjects and subject hospital rooms will be collected to do bacteria counts.
Group II: Non-copper linen exposureActive Control1 Intervention
Subjects will not have exposure to copper linens during their hospital stay. They will use the usual hospital linens provided by hospital, not containing copper.
A subset of 50 subjects from this arm will be recruited to provide three types of swabs to calculate the microbial burden on copper linens. Linen swabs, anatomical swabs and environmental swabs will be collected from subjects and subject hospital rooms will be collected to do bacteria counts.
Find a Location
Who is running the clinical trial?
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,476,817 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,503 Total Patients Enrolled
1 Trials studying Critically Ill Patients
1,609 Patients Enrolled for Critically Ill Patients
Ebbing Lautenbach, MD,MPH,MSCEPrincipal InvestigatorUniveristy of Pennsylvania
1 Previous Clinical Trials
145 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Copper linen exposure
- Group 2: Non-copper linen exposure
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger